Antigenotoxic and antimutagenic effects of lignin derivative BP-C2 against dioxidine and cyclophosphamide in vivo in murine cells

• Published in: Toxicology reports Vol. 9; pp. 743 - 749
• Main Authors: Zhanataev, Aliy K., Pigarev, Sergey E., Fedoros, Elena I., Panchenko, Andrey V., Anisina, Elena A., Chayka, Zlata V., Durnev, Andrey D., Anisimov, Vladimir N.
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier B.V 2022; Elsevier
• Subjects: Antimutagenic activity; Chromosomal aberrations; Comet assay; Genoprotective activity; Lignin; Polyphenols; Regular; Polyphenols; Lignin; Chromosomal aberrations; Genoprotective activity; Antimutagenic activity; Comet assay
• ISSN: 2214-7500; 2214-7500
• DOI: 10.1016/j.toxrep.2022.03.041

The study investigated antigenotoxic and antimutagenic activity of novel lignin-derived polyphenolic composition (BP-C2) with ammonium molybdate towards cyclophosphamide and dioxidine in the bone marrow, blood and liver cells of BALB/c mice. BP-C2 was given to mice via gavage at 60, 80 and 120 mg/kg once 1 h before single intraperitoneal injection of a genotoxic agent. 1.5 h and 3 h after dioxidine or cyclophosphamide injection, respectively, cellular suspensions were obtained from mice and assessed with the comet test and cytogenetic analysis of bone marrow cells. It was observed that antigenotoxic activity of BP-C2 against DNA damage induced by dioxidine, a prooxidant genotoxic agent, in the bone marrow, liver and blood cells of mice in vivo was more pronounced at 60 and 80 mg/kg than at 120 mg/kg. When cyclophosphamide was used to induce a DNA damage, the genoprotective effect of BP-C2 was observed in bone marrow, liver and blood cells at 60 mg/kg dose but the effect was not significant at 80 mg/kg. When co-administered with 120 mg/kg BP-C2, cyclophosphamide induced a higher level of DNA damage in liver cells, but its genotoxic effect in bone marrow and blood cells was the same as when it was administered alone. When assessing the effect of BP-C2 on chromosomal aberrations induced by cyclophosphamide and dioxidine in bone marrow cells, it was revealed that all three tested doses of BP-C2 significantly decreased the number of cells with chromosome abnormalities. Thus, BP-C2 has a pronounced antimutagenic and genoprotective effects. [Display omitted] •Lignin derivative BP-C2 mitigates genotoxic activity of dioxidine in vivo.•Lignin derivative BP-C2 mitigates genotoxic activity of cyclophosphamide in vivo.•Lignin derivative BP-C2 exhibits significant antimutagenic activity in vivo.